会讯：国际体外诊断中国峰会将于6月在北京举办！

  

国际体外诊断市场整体增速强劲，达到国际制药市场的两倍。但是随着欧美等发达体外诊断市场的增速下降，欧美体外诊断公司在寻求国际市场的合作。于此同时，亚太地区变成的体外诊断市场的一片蓝海。

  The global in vitro diagnostics (IVD) market is growing robustly - at double the rate of the global pharmaceutical industry. While the U.S. and European markets remain important, their slowdown is demanding an alignment with the global market. As a result, the Asia-Pacific region is becoming a lucrative destination for IVD manufacturers.

  随着中国的利好政策，中国的体外诊断行业复合增长率最高。另外，随着私立医院，第三方独立实验室在中国的快速增长，都将保障在未来的几年内这种增速将保持。但是，制约企业快速发展的问题也十分突出。缺少专业人才，定价的策略，以及中国医疗报销等等方面都将成为中国体外诊断行业的挑战。

  The China in vitro diagnostics market is segmented according to major applications into immunoassay market, clinical chemistry market, hematology market, microbiology market, molecular testing market, coagulation market, self-monitoring of blood glucose (SMBG) market, and point of care testing (POCT) market. China has become a competitive force and emerged as the world’s fastest growing IVD products market. The report states, that the China in vitro diagnostics market will double in its size by 2018 as compared to its 2013 market size

  2015国际体外诊断高峰论坛将于6月04日至05日在北京隆重召开。本届高峰论坛从全球视野的角度深入剖析中国体外诊断行业。大会两天将从以下6大方面解读：

  World IVD Conference 2015 will be held from June 04th -05th in Beijing. This decision makers gathering event will deeply outline the current China IVD industry. There would be 6 main sessions.

  Conference Day 1 | 大会第一天：

  1）New Government Regulation Implementation and Interpretation | 中国的监管条例，政策解读
  《Measures for the Administration of Registration of In-Vitro Diagnostic Reagents》.

  2）Advanced Technology, New Products Launching and Acquisition | 国体先进技术推广与产业合作

  Conference Day 2 | 大会第二天，Track 1 | 分会场一：

  3）Application and Development of POCT | POCT的发展以及市场方向

  4）Personalized Medicine and Companion Diagnostics | 个体化医疗以及伴随诊断

  Conference Day 2 | 大会第二天，Track 2 |分会场二：

  5）End-users’ Demand and Requirement | 终端市场的需求点(三甲医院，民营医院，乡村医院，血战，疾控中心，第三方实验室)

  6）Global Emerging Markets Introduction | 国际体外诊断新兴市场(印度，俄罗斯，巴西，马拉西亚)

  Guests Inviting from | 本届高峰会将邀请：

  Government Officers | 政府监管局领导：FDA(美国食品药品监督管理局), CLSI(美国临床实验室标准化协会), National Health and Family Planning Commission of the PRC(国家卫生和计划生育委员), CFDA(国家食品药品监督管理局)

  Global IVD Giants | 国际知名企业高管： QUEST, Nanosphere Technology, 华大基因

  End-Users | 终端医院临床诊断主任医师：Mayo Clinic(梅奥诊所), Brigham and Women's Hospital, (The PLA General Hospital)中国人民解放军军区总院,Peking Union Medical College Hospital( 协和医院)

  Research Institution | 科研院校学科带头人：清华大学，厦门大学，浙江大学，安徽医科大学

  Global Distributors | 国际知名经销商：P3 Medical, Euro Asia Medico, Labquip Asia Pte Ltd, Somnotec

  Investors | 投资机构：Capital Investors and pharmaceutical companies

  Register Here | 注册地址：

  Contact Organizer:

  Conference Manger: JAY TEO

  Tel: +85 (0)21 3106 9250
  Email: jay.teo@investmed.asia or info@investmed.asia （转化医学网360zhyx.com）